Gilead Sciences Announces Third Quarter 2018 Dividend

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared a cash dividend of $0.57 per share of common stock for the third quarter of 2018. The dividend is payable on September 27, 2018, to stockholders of record at the close of business on September 14, 2018. Future dividends will be subject to Board approval.

About Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180725005537/en/

Investors
Gilead Sciences, Inc.
Robin Washington, 650-522-5688
Sung Lee, 650-524-7792

Source: Gilead Sciences, Inc.

You May Also Be Interested In

• EU approves Gilead's Trodelvy for first-line metastatic TNBC
• Crombie REIT Announces Redemption of $200 Million Series F Unsecured Notes
• PersonalHour Responds to Industry Challenges by Strengthening Quality, Customer Support, and Innovation in Home Pilates